Public health experts are worried that incomplete information on the recall of the AIDS drug Viracept by the pharmaceutical company Roche is leaving AIDS victims in poor countries with a Catch-22: take their AIDS meds on schedule and risk the potential for a contaminated batch; or stop taking the drug as part of their regime, and risk the health effects of incomplete treatment.
Check out today’s New York Times for an article on the recall.